Georgia Code
Chapter 17 - Control of Sexually Transmitted Disease
§ 31-17-4.1. Chlamydia Screening Test

History. Code 1981, § 31-17-4.1 , enacted by Ga. L. 1998, p. 867, § 2; Ga. L. 2017, p. 164, § 56/HB 127.
The 2017 amendment, effective July 1, 2017, in paragraph (b)(4), substituted “this subsection” for “subsection (b) of this Code section” near the beginning and deleted “a nonprofit hospital service corporation, a nonprofit medical service corporation,” preceding “a health care” near the end.
Editor’s notes.
Ga. L. 1998, p. 867, § 1, not codified by the General Assembly, provides that: “The General Assembly finds that chlamydia is a sexually transmitted disease which may cause serious complications in persons infected with it, including pelvic inflammatory disease, infertility, and ectopic pregnancy. Pregnant women infected with chlamydia may suffer from symptoms such as stillbirths, low birth weight babies, and other serious physical and mental complications for their infants. Chlamydia is often asymptomatic in women and cannot be detected except with special, though inexpensive, screening tests. Cure of chlamydia is usually both easy and inexpensive. The General Assembly further finds that requiring health care insurance and managed care plan coverage of annual chlamydia screening tests for females in the age group most likely to be infected with chlamydia will encourage the testing and treatment needed to detect and cure this destructive disease and result in a marked improvement in the general health of the citizens of this state and the savings of both public and private moneys being spent to deal with the serious consequences of this disease.”
Law reviews.
For review of 1998 legislation relating to health, see 15 Ga. St. U. L. Rev. 130 (1998).

Structure Georgia Code